Literature DB >> 16042230

Physical activity and multiple sclerosis: a meta-analysis.

Robert W Motl1, Edward McAuley, Erin M Snook.   

Abstract

Using meta-analytic procedures, this study involved a quantitative synthesis of the difference in physical activity among individuals with multiple sclerosis (MS) compared with nondiseased and diseased populations and then examined factors (i.e., moderators) that explain variation in the overall difference in physical activity. We searched MEDLINE, PsycINFO and Current Contents Plus using the key words physical activity, exercise and physical fitness in conjunction with multiple sclerosis; conducted a manual search of bibliographies of the retrieved papers; and contacted study authors about additional studies. Overall, 53 effects were retrieved from 13 studies with 2360 MS participants and yielded a weighted mean effect size (ES) of -0.60 (95% CI = -0.44, -0.77). The weighted mean ES was heterogenous, Q = 1164.11, df = 52, P < 0.0001. There were larger effects with objective versus self-report measures of physical activity, nondiseased versus diseased populations and primary progressive versus relapsing remitting MS. The cumulative evidence suggests that individuals with MS are less physically active than nondiseased, but not diseased, populations.

Entities:  

Mesh:

Year:  2005        PMID: 16042230     DOI: 10.1191/1352458505ms1188oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  107 in total

1.  Yoga effects on physical activity and sexual satisfaction among the Iranian women with multiple sclerosis: a randomized controlled trial.

Authors:  Shahla Najafidoulatabad; Zinat Mohebbi; Khierollah Nooryan
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-08-23

2.  Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial.

Authors:  Rosaria Sacco; Rita Bussman; Peter Oesch; Jürg Kesselring; Serafin Beer
Journal:  J Neurol       Date:  2010-11-15       Impact factor: 4.849

Review 3.  Rehabilitation interventions in multiple sclerosis: an overview.

Authors:  Serafin Beer; Fary Khan; Jürg Kesselring
Journal:  J Neurol       Date:  2012-07-08       Impact factor: 4.849

Review 4.  Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

Authors:  Alexander Rae-Grant; Amy Bennett; Amy E Sanders; Michael Phipps; Eric Cheng; Christopher Bever
Journal:  Neurology       Date:  2015-09-02       Impact factor: 9.910

Review 5.  Promoting Physical Activity among Underserved Populations.

Authors:  Andrea S Mendoza-Vasconez; Sarah Linke; Mario Muñoz; Dori Pekmezi; Cole Ainsworth; Mayra Cano; Victoria Williams; Bess H Marcus; Britta A Larsen
Journal:  Curr Sports Med Rep       Date:  2016 Jul-Aug       Impact factor: 1.733

6.  Self-efficacy and environmental correlates of physical activity among older women and women with multiple sclerosis.

Authors:  Katherine S Morris; Edward McAuley; Robert W Motl
Journal:  Health Educ Res       Date:  2007-10-24

7.  ADSTEP: Preliminary Investigation of a Multicomponent Walking Aid Program in People With Multiple Sclerosis.

Authors:  Douglas N Martini; Eline Zeeboer; Andrea Hildebrand; Brett W Fling; Cinda L Hugos; Michelle H Cameron
Journal:  Arch Phys Med Rehabil       Date:  2018-06-26       Impact factor: 3.966

8.  Attitude towards physical activity in patients with multiple sclerosis: a cohort study.

Authors:  Jessica Frau; G Coghe; L Lorefice; G Fenu; B Cadeddu; M G Marrosu; E Cocco
Journal:  Neurol Sci       Date:  2015-02-04       Impact factor: 3.307

Review 9.  Secondary Progressive Multiple Sclerosis: Definition and Measurement.

Authors:  Domenico Plantone; Floriana De Angelis; Anisha Doshi; Jeremy Chataway
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

10.  Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.

Authors:  Anja Thormann; Melinda Magyari; Nils Koch-Henriksen; Bjarne Laursen; Per Soelberg Sørensen
Journal:  J Neurol       Date:  2016-10-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.